Chinese Drug Ribupatide Shows Greater Weight Loss Than Wegovy in Clinical Trial
Clinical trial results indicate that ribupatide, an experimental weight-loss medication developed by Chinese pharmaceutical company Hengrui, enabled participants to shed nearly 18% of their body weight within 48 weeks. The findings suggest the drug may outperform established GLP-1 treatments like Wegovy in efficacy and speed.